Authors: Slatter, JG Stalker, DJ Feenstra, KL Welshman, IR Bruss, JB Sams, JP Johnson, MG Sanders, PE Hauer, MJ Fagerness, PE Stryd, RP Peng, GW Shobe, EM

Citation: Jg. Slatter et al., Pharmacokinetics, metabolism, and excretion of linezolid following an oraldose of [C-14]linezolid to healthy human subjects, DRUG META D, 29(8), 2001, pp. 1136-1145

Authors: Stevens, DL Smith, LG Bruss, JB McConnell-Martin, MA Duvall, SE Todd, WM Hafkin, B

Citation: Dl. Stevens et al., Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections, ANTIM AG CH, 44(12), 2000, pp. 3408-3413

Authors: Bruss, JB Siber, GR

Citation: Jb. Bruss et Gr. Siber, Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model, CL DIAG LAB, 6(4), 1999, pp. 464-470

Authors: Bruss, JB Malley, R Halperin, S Dobson, S Dhalla, M McIver, J Siber, GR

Citation: Jb. Bruss et al., Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin, PEDIAT INF, 18(6), 1999, pp. 505-511